Topical Tranexamic Acid After Intravitreal Injections

See also
Status	Clinical Trial	Phase
Completed	`NCT04633954` - Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery	N/A
Completed	`NCT04827836` - Pain Control and Subconjunctival Hemorrhage Size After Intravitreal Injection	N/A
Not yet recruiting	`NCT04683159` - Brimonidine Tartrate for Pterygium Surgery	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT04633954 - Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery

N/A

Completed

NCT04827836 - Pain Control and Subconjunctival Hemorrhage Size After Intravitreal Injection

N/A

Not yet recruiting

NCT04683159 - Brimonidine Tartrate for Pterygium Surgery

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04400916
Study type	Interventional
Source	Rambam Health Care Campus
Contact
Status	Not yet recruiting
Phase	N/A
Start date	September 2020
Completion date	December 2021

Topical Tranexamic Acid After Intravitreal Injections

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms